TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
iSpecimen ( (ISPC) ) has provided an announcement.
On November 28, 2025, iSpecimen Inc. received confirmation from the Nasdaq Listing Qualifications Staff that it now meets the continued listing requirements under Nasdaq Listing Rules. Previously, on June 4, 2025, the company was notified of non-compliance with the minimum stockholders’ equity, market value of listed securities, or net income requirements. However, as of September 30, 2025, iSpecimen reported stockholders’ equity of $3,072,711, regaining compliance and closing the matter.
The most recent analyst rating on (ISPC) stock is a Sell with a $0.40 price target. To see the full list of analyst forecasts on iSpecimen stock, see the ISPC Stock Forecast page.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Underperform.
iSpecimen’s overall stock score is primarily impacted by its weak financial performance and poor valuation metrics. The company’s declining revenues, negative profitability, and cash flow issues are significant concerns. Additionally, bearish technical indicators and a lack of earnings or dividends further contribute to the low score. Strategic improvements are necessary to enhance the company’s financial health and market perception.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
Average Trading Volume: 6,762,818
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.1M
For an in-depth examination of ISPC stock, go to TipRanks’ Overview page.